|
Study: Citizen Petition Changes Not Stopping Brand Tactic
A provision in the 2007 FDA Amendments Act (FDAAA) intended to limit citizen petitions that block generic drug approvals has failed to change the behavior of brand companies, whose use of the petitions continues to rise, according to a new study.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives